Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.

To identify appropriate candidates for aggressive treatment such as radical prostatectomy or radiation therapy of localized prostate cancer (PCa), novel predictive biomarkers of PCa aggressiveness are essential. Core2 β-1,6-N-acetylglucosaminyltransferase-1 (GCNT1) is a key enzyme that forms core 2-...

Full description

Bibliographic Details
Main Authors: Yuta Kojima, Tohru Yoneyama, Shingo Hatakeyama, Jotaro Mikami, Tendo Sato, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda, Yuki Tobisawa
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4577128?pdf=render
_version_ 1828389516649431040
author Yuta Kojima
Tohru Yoneyama
Shingo Hatakeyama
Jotaro Mikami
Tendo Sato
Kazuyuki Mori
Yasuhiro Hashimoto
Takuya Koie
Chikara Ohyama
Minoru Fukuda
Yuki Tobisawa
author_facet Yuta Kojima
Tohru Yoneyama
Shingo Hatakeyama
Jotaro Mikami
Tendo Sato
Kazuyuki Mori
Yasuhiro Hashimoto
Takuya Koie
Chikara Ohyama
Minoru Fukuda
Yuki Tobisawa
author_sort Yuta Kojima
collection DOAJ
description To identify appropriate candidates for aggressive treatment such as radical prostatectomy or radiation therapy of localized prostate cancer (PCa), novel predictive biomarkers of PCa aggressiveness are essential. Core2 β-1,6-N-acetylglucosaminyltransferase-1 (GCNT1) is a key enzyme that forms core 2-branched O-glycans. Its expression is associated with the progression of several cancers. We established a mouse IgG monoclonal antibody (mAb) against GCNT1 and examined the relationship of GCNT1 expression to the clinicopathological status of PCa. Paraffin-embedded PCa specimens were analyzed by immunohistochemistry for GCNT1 expression using a newly established mouse anti-GCNT1 mAb by ourselves. GCNT1-positive tumor showed significantly higher Gleason score and larger tumor volume. The number of GCNT1-positive cases was significantly lower in cases of organ-confined disease than in cases of extracapsular extension. GCNT1-negative tumors were associated with significantly better prostate-specific antigen (PSA)-free survival compared with GCNT1-positive tumors. Multivariate analysis revealed that detection of GCNT1 expression was an independent risk factor for PSA recurrence. We established new methods for GCNT1 detection from PCa specimens. Immunoblotting was used to examine post-digital rectal examination (DRE) urine from PCa patients. Over 90% of GCNT1-positive PCa patients with high concentrations of PSA showed extracapsular extension. In conclusion, GCNT1 expression closely associates with the aggressive potential of PCa. Further research aims to develop GCNT1 detection in post-DRE urine as a marker for PCa aggressiveness.
first_indexed 2024-12-10T06:30:25Z
format Article
id doaj.art-7118485b5a1546bc8235420ec3dd2832
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T06:30:25Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7118485b5a1546bc8235420ec3dd28322022-12-22T01:59:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013852010.1371/journal.pone.0138520Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.Yuta KojimaTohru YoneyamaShingo HatakeyamaJotaro MikamiTendo SatoKazuyuki MoriYasuhiro HashimotoTakuya KoieChikara OhyamaMinoru FukudaYuki TobisawaTo identify appropriate candidates for aggressive treatment such as radical prostatectomy or radiation therapy of localized prostate cancer (PCa), novel predictive biomarkers of PCa aggressiveness are essential. Core2 β-1,6-N-acetylglucosaminyltransferase-1 (GCNT1) is a key enzyme that forms core 2-branched O-glycans. Its expression is associated with the progression of several cancers. We established a mouse IgG monoclonal antibody (mAb) against GCNT1 and examined the relationship of GCNT1 expression to the clinicopathological status of PCa. Paraffin-embedded PCa specimens were analyzed by immunohistochemistry for GCNT1 expression using a newly established mouse anti-GCNT1 mAb by ourselves. GCNT1-positive tumor showed significantly higher Gleason score and larger tumor volume. The number of GCNT1-positive cases was significantly lower in cases of organ-confined disease than in cases of extracapsular extension. GCNT1-negative tumors were associated with significantly better prostate-specific antigen (PSA)-free survival compared with GCNT1-positive tumors. Multivariate analysis revealed that detection of GCNT1 expression was an independent risk factor for PSA recurrence. We established new methods for GCNT1 detection from PCa specimens. Immunoblotting was used to examine post-digital rectal examination (DRE) urine from PCa patients. Over 90% of GCNT1-positive PCa patients with high concentrations of PSA showed extracapsular extension. In conclusion, GCNT1 expression closely associates with the aggressive potential of PCa. Further research aims to develop GCNT1 detection in post-DRE urine as a marker for PCa aggressiveness.http://europepmc.org/articles/PMC4577128?pdf=render
spellingShingle Yuta Kojima
Tohru Yoneyama
Shingo Hatakeyama
Jotaro Mikami
Tendo Sato
Kazuyuki Mori
Yasuhiro Hashimoto
Takuya Koie
Chikara Ohyama
Minoru Fukuda
Yuki Tobisawa
Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
PLoS ONE
title Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
title_full Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
title_fullStr Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
title_full_unstemmed Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
title_short Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
title_sort detection of core2 β 1 6 n acetylglucosaminyltransferase in post digital rectal examination urine is a reliable indicator for extracapsular extension of prostate cancer
url http://europepmc.org/articles/PMC4577128?pdf=render
work_keys_str_mv AT yutakojima detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer
AT tohruyoneyama detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer
AT shingohatakeyama detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer
AT jotaromikami detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer
AT tendosato detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer
AT kazuyukimori detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer
AT yasuhirohashimoto detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer
AT takuyakoie detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer
AT chikaraohyama detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer
AT minorufukuda detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer
AT yukitobisawa detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer